On-Demand Webinars

31. Elevate Your Protein Production With SynWeave™ 6/15/2026

    Sunit Maity, Ph.D., Senior GM – Biologics Services, introduces an advanced platform that combines state-of-the-art cell line and transposon-based technologies from ExcellGene.

32. Enabling Clinical-Grade Automated Manufacturing Of γδ T Cells 6/12/2026

    Explore smarter approaches to γδ T cell manufacturing, including scalable expansion, efficient transduction, and streamlined analytics, as well as how to build workflows that support validation.

33. Establishing The First Chinese Haplobank Of Clinical-Grade hiPSCs 6/11/2026

    Learn how automated, closed workflows and GMP-ready infrastructure are advancing pluripotent stem cell development from scalable expansion and differentiation to building regional capacity.

34. Achieving Clinical Quality For Human iPSC Generation And Expansion 6/11/2026

    Gain practical insight into building scalable stem cell manufacturing processes while maintaining consistency and quality across workflows, as well as in-depth guidance to support your strategy.

35. Automated GMP-Compliant PSC Banking In A Closed System 6/11/2026

    Explore advances in automated adherent cell culture and the optimization of large-scale iPSC expansion, as well as how standardization and process control are improving reproducibility.

36. Manufacturing GMP-Compliant iPSCs In Closed And Open Systems 6/11/2026

    Gain practical insight into scaling human iPSC manufacturing with expert perspectives on process control, reproducibility, and automated workflows designed to support stem cell expansion.

37. Advancing Clinical-Grade TIL Therapy Manufacturing 6/11/2026

    TIL therapy continues to advance, but manufacturing complexity limits its potential. See how automated workflows for generating tumor-reactive T cells can improve consistency, scalability, and readiness.

38. Automated And Streamlined Manufacturing Of TIL Therapies 6/11/2026

    Advances in TIL therapy are driving a shift from manual processes to streamlined, automated manufacturing. Discover how improved workflows and early clinical results are shaping cancer treatments.

39. Using Residual DNA Quantification Data To De-Risk mAb Development 6/11/2026

    Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

40. The AI Advantage For Regulated Manufacturing 6/10/2026

    Transitioning from paper batch records to human-centered AI optimizes pharma manufacturing. Learn to secure data, cut review times by 90%, and build a strong Return on Automation business case.